Advertisement

Topics

ASCO 2017: Dendreon Announces New Prostate Cancer Data for Provenge

08:51 EDT 6 Jun 2017 | Drug Discovery Development

Treatment with PROVENGE induces a patient’s immune system to generate a response to both PA2024 and PAP.

Original Article: ASCO 2017: Dendreon Announces New Prostate Cancer Data for Provenge

NEXT ARTICLE

More From BioPortfolio on "ASCO 2017: Dendreon Announces New Prostate Cancer Data for Provenge"

Quick Search
Advertisement